Arcadia Biosciences Inc (RKDA)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -30.002 | -42.948 | -66.414 | -101.788 | -11.649 | -32.126 | -42.219 | -57.503 |
Return on Equity (%) | -62.874 | -104.003 | -129.478 | -272.504 | -25.245 | -49.073 | -59.029 | -83.213 |
Return on Invested Capital (%) | -42.864 | -57.063 | -179.189 | -192.639 | -127.242 | -106.735 | -79.933 | -95.199 |
Operating Margin (%) | -573.4 | -370.939 | -920.082 | -2469.29 | -75.965 | -237.64 | -156.669 | -246.848 |
Net Profit Margin (%) | -615.558 | -390.139 | -920.765 | -2464.072 | -57.941 | -216.224 | -154.44 | -262.308 |
Book Value Per Share | 0.499 | 3.752 | 2.684 | 0.963 | 2.065 | 1.384 | 24.312 | 11.409 |
Earnings Per Share | -0.441 | -7.36 | -2.823 | -3.332 | -0.346 | -0.661 | -17.921 | -12.595 |
Cash Per Share | 0.045 | 4.276 | 2.513 | 0.974 | 1.044 | 1.293 | 24.061 | 5.872 |
Working Capital Per Share | 1.104 | 5.399 | 4.151 | 2.629 | 1.887 | 1.368 | 24.696 | 10.254 |
Operating Profit Per Share | 0.058 | 1.885 | 0.2 | 0.171 | 0.26 | -0.04 | 0.738 | 2.087 |
EBIT Per Share | -0.441 | -7.348 | -2.821 | -3.339 | -0.457 | -0.727 | -18.179 | -11.853 |
EBITDA Per Share | -0.441 | -7.348 | -2.821 | -3.339 | -0.457 | -0.727 | -18.179 | -11.853 |
Free Cash Flow Per Share | -0.443 | -7.454 | -2.803 | -3.183 | -0.222 | -0.663 | -18.395 | -12.85 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 44,49M | 2,13M | 4,78M | 8,65M | 13,45M | 22,18M | 858k | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 858k | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -621.869 | N/A | N/A | N/A | -193.068 | N/A | N/A |
Net Profit Margin (%) | N/A | -621.869 | N/A | N/A | N/A | -193.068 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 7,1M |
Ratio cours/bénéfice | -0,51 |
Ratio prix/ventes | 1,33 |
Ratio prix/liquidités | 1,09 |
Ratio prix/valeur comptable | 0,56 |
Rendement de dividende | - |
Actions en circulation | 1,36M |
Volume moyen (1 semaine) | 23,12k |
Volume moyen (1 mois) | 26,47k |
Variation sur 52 semaines | 102,33% |
Plus haut sur 52 semaines | 10,3099 |
Plus bas sur 52 semaines | 1,8512 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales